EVGN logo

Evogene Ltd.

EVGN
Healthcare|Biotechnology|IL
$0.27
-0.06 (-17.78%)
Tangible Book / Share
$0.47
Cash / Share
$0.76
Next Earnings Report
Nov 19, 2026
EPS est. -$0.19 · Revenue est. $365.0K
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Jul 17, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Evogene Schedules Third Quarter 2026 Financial Results Release
Nov 5, 2026 · PRNewsWire
Evogene Announces Acute Graft-Versus-Host Disease (aGVHD) as the Target Indication for Its Internal AI-Driven Drug Discovery Program
Oct 28, 2026 · PRNewsWire
Evogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in Spain
Oct 26, 2026 · PRNewsWire
Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL
Oct 20, 2026 · PRNewsWire
Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors
Oct 6, 2026 · PRNewsWire
Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance
Sep 30, 2026 · PRNewsWire
EverGen to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto
Sep 14, 2026 · Newsfile Corp
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward
Aug 31, 2026 · PRNewsWire
EverGen Infrastructure Reports Q2 2026 Results
Aug 27, 2026 · Business Wire
EverGen Infrastructure Announces Voting Results for the Annual General Meeting of Shareholders Held on August 25, 2026
Aug 26, 2026 · Business Wire

SEC Filings (76)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 28, 20266-KForeign issuer reportDocumentIndex
Oct 6, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Oct 6, 20266-KForeign issuer reportDocumentIndex
Sep 30, 20266-KForeign issuer reportDocumentIndex
Sep 29, 2026EFFECTDocumentIndex
Sep 28, 20266-KForeign issuer reportDocumentIndex
Sep 28, 2026POS AMDocumentIndex
Sep 15, 20266-KForeign issuer reportDocumentIndex
Sep 11, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Sep 11, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Sep 4, 20266-KForeign issuer reportDocumentIndex
Aug 28, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Aug 27, 20266-KForeign issuer reportDocumentIndex
Aug 18, 20266-KForeign issuer reportDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 13, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Aug 13, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Aug 11, 2026SC 13DActivist / 5%+ stakeDocumentIndex
Aug 7, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jul 31, 20266-KForeign issuer reportDocumentIndex
Jul 27, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jul 20, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jul 17, 2026424B5Offering prospectusDocumentIndex
Jul 17, 20266-KForeign issuer reportDocumentIndex
Jul 10, 2026SC 13DActivist / 5%+ stakeDocumentIndex
Jun 16, 20266-KForeign issuer reportDocumentIndex
Jun 11, 2026424B5Offering prospectusDocumentIndex
Jun 11, 20266-KForeign issuer reportDocumentIndex
May 20, 2026424B3Offering prospectusDocumentIndex
May 20, 20266-KForeign issuer reportDocumentIndex
May 18, 20266-KForeign issuer reportDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
Apr 15, 2026EFFECTDocumentIndex
Apr 3, 2026EFFECTDocumentIndex
Apr 2, 20266-KForeign issuer reportDocumentIndex
Mar 26, 2026F-3Shelf registrationDocumentIndex
Mar 26, 2026S-8Employee stock planDocumentIndex
Mar 26, 2026POS AMDocumentIndex
Mar 26, 202620-FAnnual report (foreign)DocumentIndex
Mar 5, 20266-KForeign issuer reportDocumentIndex